Honestly, deals are nice. They're a measurable metric, and they up the bidding price for any potential takeover. But for me, the big money is really made when the peptide libraries are proven useful for something profitable - a delivery mechanism for a valuable drug, for example. I'd much rather see a announcement like "Roche goes into Phase 1 clinical trials for new cancer drug".
pre final report, page-10
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.015(13.6%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.5¢ | 11.0¢ | $210.2K | 1.809M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 202595 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 590336 | 11 |
View Market Depth
| Last trade - 13.08pm 22/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |